Live Breaking News & Updates on Autoimmune Myasthenia

Stay updated with breaking news from Autoimmune myasthenia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investigative Celiac Disease Drug KAN-101 Safe, Tolerable in Phase 1 Study

Early-stage data support KAN-101, a liver-targeting drug that's vying to become the first treatment approved to treat celiac disease. ....

Deborah Geraghty , Linkedin Kristiem Grebe , Kristiem Grebe , Drug Administration , Kan 101 , Phase 1 ,

Disease Activity–Guided Dosing Safe, Effective for Up to 10 Years in Rheumatoid Arthritis

Noortje van Herwaarden, MD, PhD, discusses the results of a 10-year follow-up from the DRESS study and how it informs use of disease activity-guided dose optimization in treatment of rheumatoid arthritis. ....

Linkedin Noortje Van Herwaarden , Noortje Van Herwaarden , Radboud University Medical Center , European Congress , Dose Reduction Strategy , Disease Activity Score , C Reactive Protein , Rheumatoid Arthritis ,

Microscopic Polyangiitis (MPA) - Cause - Symptoms - Signs - Diagnosis

Microscopic polyangitis, infection of small blood vessels, presents with general symptoms of fever, muscle pain and weight loss. Localized symptoms can also occur. ....

United States , Kevink Brown , Simi Paknikar , Stephenk Frankel , Santhosh Babu , Eugenej Sullivan , Internal Medicine , Care Clin , Microscopic Polyangiitis , Pulmonary Fibrosis , Patient Alert , Sugar Clinic , Asculitis Symptoms , Granulomatosis With Polyangiitis , Polyarteritis Nodosa ,

MyJournals.org - Science - 'Advanced methods and novel biomarkers in autoimmune diseases â€` a review of the recent years progress in systemic lupus erythematosus' (Frontiers in Medicine)

MyJournals.org - Science - 'Advanced methods and novel biomarkers in autoimmune diseases â€` a review of the recent years progress in systemic lupus erythematosus' (Frontiers in Medicine)
myjournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from myjournals.org Daily Mail and Mail on Sunday newspapers.

Immutep : to Participate at the Jefferies Healthcare Conference

SYDNEY, AUSTRALIA, June 07, 2023 Immutep Limited , a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces. | June 7, 2023 ....

New York , United States , New South Wales , Marc Voigt , Immutep Limited , Jefferies Healthcare Conference , New York City , Lymphocyte Activation , Immutep Limited Stock Exchange , Press Release , Oday Imm Au000000imm6 ,